Steroid Non-responsive Hashimoto's Encephalopathy Improved by Rituximab
Journal of the Korean Neurological Association
; : 19-21, 2018.
Article
in Ko
| WPRIM
| ID: wpr-766632
Responsible library:
WPRO
ABSTRACT
Hashimoto's encephalopathy is a rare autoimmune disease, with symptoms of encephalopathy and high titers of serum anti-thyroid antibodies. Current diagnostic criteria include corticosteroid responsiveness, but in some cases, they are refractory to corticosteroids. In steroid non-responders, other immunomodulatory therapies could be applied. Recently, Rituximab is reported as a safe and effective treatment for Hashimoto's encephalopathy. We report a 50-year-old woman with Hashimoto's encephalopathy presented with confusion and catatonia who was refractory to corticosteroid and immunoglobulin but effectively treated with rituximab.
Key words
Full text:
1
Index:
WPRIM
Main subject:
Autoimmune Diseases
/
Thyroid Hormones
/
Brain Diseases
/
Immunoglobulins
/
Catatonia
/
Adrenal Cortex Hormones
/
Immunomodulation
/
Rituximab
/
Glucocorticoids
/
Antibodies
Limits:
Female
/
Humans
Language:
Ko
Journal:
Journal of the Korean Neurological Association
Year:
2018
Type:
Article